Elastic Relief Strip

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with sore muscles and joints. Specifically, it is effective for conditions such as arthritis, backache, strains, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be cleaned and dried prior to application. For patients aged 12 years and older, the protective film should be partially peeled back to expose the adhesive strip, which is then applied directly to the site of pain. Care should be taken to remove the remaining film while pressing the strip firmly against the skin, ensuring it remains in place for a maximum duration of 4 hours. It is important that the strip is applied without stretching, allowing for a comfortable fit that is not tight. The strip may be used on the affected areas no more than 4 times daily. For optimal adhesion, the application site should be clean, dry, and smooth.

For children under 12 years of age, a physician should be consulted prior to use.

Contraindications

The product is contraindicated in the following situations:

Application to wounds or damaged skin is prohibited due to the risk of exacerbating injury or infection. The use of this product in conjunction with other ointments, creams, sprays, or liniments is not recommended, as it may lead to adverse interactions or reduced efficacy. Application to irritated skin is also contraindicated, as it may worsen irritation or cause further discomfort.

Additionally, overwrapping or wrapping strips over themselves is not permitted, as this may compromise the product's effectiveness and safety. Bandaging the area or using a heating pad or device concurrently is contraindicated due to the potential for increased irritation or thermal injury.

Contact with eyes or mucous membranes should be strictly avoided to prevent irritation or injury.

Warnings and Precautions

For external use only, this product must be utilized strictly as directed. It is imperative to avoid contact with the eyes or mucous membranes, as such exposure may lead to adverse effects. Application to wounds or damaged skin is contraindicated, and the product should not be used in conjunction with other ointments, creams, sprays, or liniments. Additionally, it is essential to refrain from applying the product to irritated skin.

Care should be taken to avoid overwrapping or wrapping strips over themselves, as this may compromise the effectiveness of the treatment. Bandaging the area or using a heating pad or device in conjunction with this product is also not recommended. Following application, hands should be washed thoroughly with cool water to prevent unintentional transfer of the product.

Healthcare professionals should advise patients to discontinue use and consult a physician if they experience any of the following: pain, swelling, or blistering; worsening of the condition; or if symptoms persist for more than seven days, or clear up only to recur within a few days. These precautions are critical to ensure the safe and effective use of the product.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. This product is intended for external use only and should be used strictly as directed. It is crucial to avoid contact with the eyes or mucous membranes and not to apply it to wounds or damaged skin. Additionally, the product should not be used in conjunction with other ointments, creams, sprays, or liniments, nor should it be applied to irritated skin. Overwrapping or wrapping strips over themselves is not recommended, and the product should not be bandaged or used with heating pads or devices.

Patients are advised to discontinue use and consult a healthcare professional if they experience any of the following: pain, swelling, or blistering; worsening of the condition; or if symptoms persist for more than 7 days, or clear up and then recur within a few days. These reactions warrant immediate medical attention to ensure patient safety and appropriate management.

Drug Interactions

Co-administration of this medication with other topical formulations, including ointments, creams, sprays, or liniments, is contraindicated. The use of multiple topical products may lead to altered absorption, increased risk of local irritation, or diminished therapeutic efficacy. It is advised to avoid concurrent use to ensure optimal treatment outcomes and minimize potential adverse effects.

Packaging & NDC

Below are the non-prescription pack sizes of Elastic Relief Strip (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a physician prior to use. For adolescents aged 12 years and older, the application involves cleaning and drying the affected area, partially peeling back the protective film, and applying the exposed strip to the site of pain. The remaining film should be carefully removed while pressing the strip to the skin, ensuring it is left in place for up to 4 hours. It is important that the strip is applied comfortably without stretching, and it should not be used on affected areas more than 4 times daily. For optimal adhesion, the application site should be clean, dry, and smooth.

In addition, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

Geriatric Use

Elderly patients do not have specific geriatric use considerations, dosage adjustments, or safety concerns associated with the use of ELASTIC RELIEF STRIP (menthol patch) as indicated in the provided drug insert. Therefore, healthcare providers may administer this product to geriatric patients without the need for modifications based on age. However, as with all medications, it is advisable to monitor elderly patients for any unexpected reactions or side effects during treatment.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully evaluated in these populations to ensure maternal and fetal safety.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

There is currently no available information regarding teratogenic or non-teratogenic effects associated with the compound. Additionally, no data has been provided concerning nonclinical toxicology, including animal pharmacology and toxicology. As such, the assessment of potential risks related to these aspects remains undetermined.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children and to seek medical help or contact a Poison Control Center immediately if the product is accidentally ingested. Patients should be instructed to use the medication only as directed and to avoid contact with the eyes or mucous membranes.

It is important to inform patients not to apply the medication to wounds or damaged skin, and to refrain from using it in conjunction with other ointments, creams, sprays, or liniments. Patients should also be cautioned against applying the medication to irritated skin and should not overwrap or allow strips to wrap over themselves.

After application, patients should wash their hands with cool water to prevent unintentional contact with other areas of the body. They should be advised not to bandage the area or use a heating pad or device in conjunction with the medication.

Patients should be instructed to stop use and consult a doctor if they experience pain, swelling, or blistering; if their condition worsens; or if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is recommended to store the product in a cool, dry place, ensuring that it is kept away from direct sunlight to maintain its integrity and efficacy. Proper storage conditions are crucial for preserving the quality of the product throughout its shelf life.

Additional Clinical Information

The route of administration for the product is topical. For patients aged 12 years and older, the affected area should be cleaned and dried before application. The protective film should be partially peeled back to expose the strip, which is then applied to the site of pain. The remaining film should be carefully removed while pressing the strip to the skin, ensuring it is left in place for up to 4 hours. It is important not to stretch the strip during application, as it should fit comfortably without being tight. The strip may be used on affected areas no more than four times daily, and for optimal adhesion, the area should be clean, dry, and smooth.

Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. Additionally, the product should be kept out of reach of children, and in the event of accidental ingestion, medical assistance or contact with a Poison Control Center is recommended.

Drug Information (PDF)

This file contains official product information for Elastic Relief Strip, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)